Hydrogels for biomedical applications from glycol chitosan and PEG diglycidyl ether exhibit pro-angiogenic and antibacterial activity

Carbohydr Polym. 2018 Oct 15:198:124-130. doi: 10.1016/j.carbpol.2018.06.061. Epub 2018 Jun 18.

Abstract

We aimed at producing a hydrogel from a chitosan (CS) derivative soluble in physiological conditions to avoid any purification step thus allowing to use the materials also as an in-situ forming material. So, we crosslinked glycol chitosan (GCS) with poly(ethylene glycol) diglycidyl ether (PEGDE) in water at 37 °C. The scaffolds, referred as GCS-PEG, were specifically designed to be used as wound dressing materials as such (after crosslinking) or as in-situ forming materials. Different amounts of PEGDE were tested. The obtained scaffolds showed macroscopic pores and a tailorable swelling in water by controlling the crosslinking degree. Moreover, GCS-PEG scaffolds displayed a significant antimicrobial activity against Staphylococcus aureus. In-vivo study using the chick embryo choriallantoic membrane resulted in a highly pronounced pro-angiogenic activity suggesting important tissue regeneration properties. Moreover, the employed materials are commercially available, no organic solvents are required and the scaling up is quite predictable.

Keywords: Angiogenesis; Antibacterial; Crosslinking; Ethylene glycol diglycidyl ether (PubMed CID: 16683); Glycol chitosan; Glycol chitosan (PubMed CID: 131636552); Hydrogel; PEG diglycidyl ether.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Chick Embryo
  • Chitosan / chemistry
  • Chitosan / pharmacology*
  • Epoxy Resins / chemistry
  • Epoxy Resins / pharmacology*
  • Hydrogels / chemistry
  • Hydrogels / pharmacology*
  • Neovascularization, Physiologic / drug effects*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / growth & development

Substances

  • Anti-Bacterial Agents
  • Epoxy Resins
  • Hydrogels
  • glycol-chitosan
  • Quetol 651
  • Chitosan